Association of 17-β Estradiol with Adipose-Derived Stem Cells: New Strategy to Produce Functional Myogenic Differentiated Cells with a Nano-Scaffold for Tissue Engineering
Open Access
- 26 October 2016
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (10) , e0164918
Abstract
The increased incidence of stress urinary incontinence (SUI) in postmenopausal women has been proposed to be associated with a reduction in the level of 17-β estradiol (E2). E2 has also been shown to enhance the multi-differentiation ability of adipose-derived stem cells (ASCs) in vitro. However, studies on the potential value of E2 for tissue engineering in SUI treatment are rare. In the present study, we successfully fabricated myogenically differentiated ASCs (MD-ASCs), which were seeded onto a Poly(l-lactide)/Poly(e-caprolactone) electrospinning nano-scaffold, and incorporated E2 into the system, with the aim of improving the proliferation and myogenic differentiation of ASCs. ASCs were collected from the inguinal subcutaneous fat of rats. The proliferation and myogenic differentiation of ASCs, as well as the nano-scaffold biocompatibility of MD-ASCs, with or without E2 supplementation, were investigated. We demonstrated that E2 incorporation enhanced the proliferation of ASCs in vitro, and the most optimal concentration was 10−9 M. E2 also led to modulation of the MD-ASCs phenotype toward a concentrated type with smooth muscle-inductive medium. The expression of early (alpha-smooth muscle actin), mid (calponin), and late-stage (myosin heavy chain) contractile markers in MD-ASCs was enhanced by E2 during the different differentiation stages. Furthermore, the nano-scaffold was biocompatible with MD-ASCs, and cell proliferation was significantly enhanced by E2. Taken together, these results demonstrate that E2 can enhance the proliferation and myogenic differentiation of ASCs and can be used to construct a biocompatible cell/nano-scaffold. These scaffolds with desirable differentiation cells show promising applications for tissue engineering.Keywords
Funding Information
- National Natural Science Foundation of China (81270851)
- National Natural Science Foundation of China (31570988)
- Innovation Foundation of Huazhong University of Science and Technology (0118540191)
This publication has 52 references indexed in Scilit:
- Electrospun Poly(L-lactide)/Poly(ε-caprolactone) Blend Nanofibrous Scaffold: Characterization and Biocompatibility with Human Adipose-Derived Stem CellsPLOS ONE, 2013
- Estrogen-related receptor α regulates osteoblast differentiation via Wnt/β-catenin signalingJournal of Molecular Endocrinology, 2012
- Phenotypic changes in cultured smooth muscle cells: limitation or opportunity for tissue engineering of hollow organs?Journal of Tissue Engineering and Regenerative Medicine, 2011
- Molecular Regulation of Contractile Smooth Muscle Cell Phenotype: Implications for Vascular Tissue EngineeringTissue Engineering Part B: Reviews, 2010
- Incidence of and Risk Factors for Change in Urinary Incontinence Status in a Prospective Cohort of Middle-Aged and Older Women: The Reproductive Risk of Incontinence Study in KaiserJournal of Urology, 2010
- The Effects of 17-β Estradiol on Enhancing Proliferation of Human Bone Marrow Mesenchymal Stromal Cells In VitroStem Cells and Development, 2010
- ERRα regulates osteoblastic and adipogenic differentiation of mouse bone marrow mesenchymal stem cellsBiochemical and Biophysical Research Communications, 2010
- Treatment of stress urinary incontinence with adipose tissue-derived stem cellsCytotherapy, 2010
- Steroid receptor coactivator 3 is a coactivator for myocardin, the regulator of smooth muscle transcription and differentiationProceedings of the National Academy of Sciences, 2007
- Clonogenic multipotent stem cells in human adipose tissue differentiate into functional smooth muscle cellsProceedings of the National Academy of Sciences of the United States of America, 2006